Sector News

Sobi Names Trista Morrison VP of Communications in North America

August 17, 2017
Life sciences

Sobi, a leading integrated global biopharmaceutical company dedicated to rare and difficult-to-treat diseases, announced today that Trista Morrison, an experienced corporate communications leader and former journalist, has joined the company as vice president of communications for North America.

Morrison will support Sobi’s growth in the region by building the communications function in North America and strengthening Sobi’s connection with patients, caregivers, healthcare professionals, advocacy groups and potential partners. She will also collaborate closely with the Sobi global communications team on integrated, worldwide communications initiatives.

Morrison’s more than 15 years in biopharmaceutical communications span corporate, reporter and agency roles. Most recently, Morrison served as director of corporate communications for Ironwood Pharmaceuticals, where she led internal, external and brand communications as the company transitioned from a research and development organization to a fully integrated commercial biotechnology company. Prior to her role at Ironwood, Morrison served as an editor and staff writer at BioWorld Today, covering breaking news and trends in the biopharmaceutical industry. Previously she served in various positions with biopharmaceutical-focused public relations agency Porter Novelli Life Sciences (formerly Atkins + Associates). Morrison was honored as one of PR News’ Top Women in PR in 2017, which recognizes communicators who have made bold advances in the profession.

“Sobi is a pioneer in rare and difficult-to-treat diseases, striving to create a world where patients with these conditions are diagnosed at birth and receive the care they need throughout their lives,” said Rami Levin, president of Sobi in North America. “This is an ambitious goal that requires communication and partnership between multiple stakeholders, and we look forward to working with Trista to advance this important work in North America.”

“The Sobi team is incredibly passionate about the work we do and dedicated to the patients and communities we serve. I am proud to be a part of this team and look forward to increasing our communication with key stakeholders as our business continues to grow,” said Morrison.

Source: Sobi™

comments closed

Related News

May 21, 2022

As monkeypox cases emerge in US and Europe, Bavarian Nordic inks vaccine order

Life sciences

A monkeypox outbreak is emerging in the U.S. and Europe, and at least one country is amping up countermeasure preparedness. Bavarian Nordic has secured a contract with an unnamed European country to supply its smallpox vaccine, called Imvanex in Europe, in response to the emergence of monkeypox cases, the Danish company said Thursday.

May 21, 2022

Moderna chairman Afeyan defends hiring practices after CFO debacle: report

Life sciences

Moderna’s recent chief financial officer debacle—in which Jorge Gomez departed on his second day on the job—raised questions about the company’s hiring process given its rush to global biopharma prominence. The most obvious one: How was it possible for Gomez to be hired when he was under investigation by his previous employer, Dentsply Sirona of Charlotte, N.C.

May 21, 2022

Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce

Life sciences

Merck & Co. is plucking a cancer project from the branch of Chinese-based Kelun Pharmaceutical for up to $1.4 billion, but details from the New Jersey-based Big Pharma have been hard to come by. The deal, first disclosed Monday on the Shenzhen stock exchange, has Merck handing over $47 million in upfront cash in exchange for ex-China rights to a “macromolecular tumor project.”